December 6, 2022

Dr . Peter McCullough is Being Progressively Stripped of His Healthcare Credentials

Dr . Peter McCullough, probably the most respected doctors in the world, is a beacon of light throughout this pandemic. His reward for speaking the truth? Your dog is being stripped of his credentials.

Peter McCullough is  an author associated with 677 articles   published in the scientific peer-reviewed journals. He’s one of the most well known cardiologists in the world. He’s already been right about everything through the pandemic. He has an encyclopedic memory of every paper he’s ever read. And your dog is just a wonderful, nice individual to boot. You really never fulfilled a nicer guy.

He’s sacrificed everything so he can talk the truth about the COVID insurance policies. If there was one COVID advisor that the government should be listening to, Dr . Peter McCullough would be at the top of every checklist.

So how will be he being rewarded for achieveing the courage to talk the truth?

I acquired this message from your pet this morning:

I was terminated as the Editor-In-Chief of  Cardiorenal Medication   and  Reviews in Cardiovascular Medicine   after many years of service and rising impact factors.   There was no phone call, no board meeting, no due process.   Just e-mails  or authorized letters.   Powerful dark forces are working in academic medicine to expunge any resistance to the vax.  

Yesterday I had been stripped of my plank certifications in Internal Medicine and Cardiology after years of perfect clinical overall performance, board scores, and countless peer reviewed publications.    

Nothing of this will stop until there is a “ needle in every supply. ”

Want to see what the medical record said about his termination? Here it is:

Yet another Editor-In-Chief termination for not following a narrative

Also i received this message through Dr . Ronald Kostoff exactly who authored a paper showing how deadly the vaccines are:

The EIC of As well as Chemical Toxicology (FCT) provides resigned.   Based on their letter below, there are myriad reasons, but I suspect the main one is the pushback through having published the Seneff et al article.   In my view, this does not bode well for the Seneff article.   Hope I’m wrong.

Here is the email the Editor-in-Chief sent out:

From:   José Luis Domingo Roig   < joseluis. domingo@urv. cat >
Date: Fri, Oct 28, 2022 at 6: 17 AM
Subject matter: My resignation as Editor-in-Chief of FCT induced by PUBLISHER. Currently FCT is really a BLUFF!
To: < redacted>

Beloved colleagues/friends (1st  relation),  

Due to   deep discrepancies in the way of directing FCT in latest month s, a couple of days ago (October 16th) We sent to our Publisher, Jagna Mirska, a resignation information and early termination associated with my agreement with FCT (my current contract would end on December thirty-one, 2023). The resignation has been accepted yesterday. It means that I will end of receiving new submissions on November 6th (21 days after the date of resignment, based on the clausula of the agreement).  

Firstly, I would like to thank your valuable assist during the 6 years and ten months in which I have been the particular Editor-in-Chief (EiC) of the Journal. Of course , without your beneficial collaboration as Editors, AEs, authors and reviewers, the  great achievements of FCT would have not been possible. You will remember that in 2021, FCT reached the first placement (according to the Clarivate IF) among all the Journals upon general toxicology. We were going for an IF = 7. 0, never reached just before by a toxicology journal. To any extent further, and with the new EiC, strangely enough appointed before being my resignation accepted, Dr Bryan Delaney (according to Scopus, he has 57 documents plus h-index: 20), I am afraid you can forget about this.  

I ignore if you are aware of this. The significant decrease in the IN THE EVENT THAT (from 6. 0 in 2020 to 5. 5 in 2021) was due to the fact Clarivate included the RIFM documents published in FCT as citable items. Since i have was appointed EiC associated with FCT, the IF had been continuously increasing until surpassing that of Arch Toxicol, doubtless the Journal #1 throughout years in general toxicology. I cannot understand why Clarivate included the RIFM documents as citable items, when it is evident they are not scientific papers. However , in spite of my claims to the particular Publisher, I have no record on the negotiations between Clarivate and the Direction of FCT to solve this incongruity. It would appear that for the Direction of FCT, the IF is not something sufficiently important for the respect of the Journal. The IN THE EVENT THAT is something important just for all of us, but not for them. The economic benefits obtained using the publication of the RIFM files are doubtless much more important. I have never been educated on the sum obtained by publishing these documents, which are a drag for the IN THE EVENT THAT of FCT.  

On the other hand, since a few months ago FCT is the Official Record of the Chinese SOT, an additional of my points or worry. Right now, more than 70-75% of our submissions come from China. If some of my main concerns experienced always been the lack of submissions through expert authors in Canada-USA/Europe, who can think that being today FCT the official journal from the Chinese SOT, this will increase the number of US/European good distribution? I do believe that just on the contrary. In a couple of years, the papers from non-Chinese authors will be the exception.  

Just a couple of years ago -and this is written- the Publisher of FCT suggested to me that people should be very careful with the variety of papers accepted from Chinese colleagues. Interestingly, 2 years afterwards, FCT is the Official Diary of the Chinese SOT. I am certain that the Publisher did not tell them -when the agreement has been signed- on her previous suggestion. However , I assume that the contract with the Chinese SOT ought to mean a good (economic) shot for the Journal and she and her Bosses will be joyful.  

Last, but not the least. A few months ago, We published in FCT an Editorial on the lack of books of studies on the potential toxicological effects of the vaccines for the COVID-19. I have no proof, just feelings, yet I think that the Editorial -and its consequences, among others, having a Review-paper published in FCT that I have not allowed to retract- was the final nail within my coffin.  

Doubtless, and based on the almost 7 years as EiC, I should highlight that will the  commercial passions and economic benefits are the main priority in FCT.   No the standard of the papers, and the respect of the Journal based on the WHEN.  

Economic benefits are currently the most important for the Direction of FCT . The scientific interest is just for us, the writers, who pay for publishing in Open Access, for the reviewers who work for nothing (sooner than late the reviewer will be paid), and for many Editors -like me- who have not had an only day of vacation in the last 7 years. All of you, who have contacted me during that time, know well this how quick are my responses.  

We are fully disappointed with the Path of FCT . Instead of solving the above indicated difficulties -created by them-  they have accepted rapidly my resignment, because probably I used to be going a burden for them. It does not matter what you and I have done by Journal. Science is not their own business although they try to dress it as such. A BIG THEN LIE!  

I would sincerely appreciate your ideas and ask for your support in the manner that you feel more appropriate. A great response could be to quarantine FCT (without agreeing to review or even publish) until the Direction determine that the scientific issues are a priority. I may be deluded, but maybe we can.  

Thanks again for your valuable help during these yrs.  

The best,  

Jose L 

PS. Please pass this information to your colleagues. Thank you 

Dr Jose L. Domingo
Distinguished  Professor (Emeritus) of Toxicology and Environmental Health
Universitat Rovira i Virgili, School of Medicine
Sant Llorens 21, 43201 Reus, SPAIN
Tel: 34 977 759380; Fax: 977 759322; e-mail:   joseluis. domingo@urv. cat

Leave a Reply

Your email address will not be published. Required fields are marked *